Annual FCF
-$23.61 M
+$26.30 M+52.70%
December 31, 2023
Summary
- As of February 8, 2025, OCX annual free cash flow is -$23.61 million, with the most recent change of +$26.30 million (+52.70%) on December 31, 2023.
- During the last 3 years, OCX annual FCF has risen by +$3.60 million (+13.24%).
- OCX annual FCF is now -3111.70% below its all-time high of -$735.00 thousand, reached on December 31, 2013.
Performance
OCX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$5.64 M
+$531.00 K+8.61%
September 30, 2024
Summary
- As of February 8, 2025, OCX quarterly free cash flow is -$5.64 million, with the most recent change of +$531.00 thousand (+8.61%) on September 30, 2024.
- Over the past year, OCX quarterly FCF has dropped by -$1.85 million (-48.92%).
- OCX quarterly FCF is now -3121.71% below its all-time high of -$175.00 thousand, reached on March 31, 2015.
Performance
OCX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$20.35 M
-$1.85 M-10.01%
September 30, 2024
Summary
- As of February 8, 2025, OCX TTM free cash flow is -$20.35 million, with the most recent change of -$1.85 million (-10.01%) on September 30, 2024.
- Over the past year, OCX TTM FCF has increased by +$9.02 million (+30.71%).
- OCX TTM FCF is now -11528.00% below its all-time high of -$175.00 thousand, reached on March 31, 2015.
Performance
OCX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
OCX Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +52.7% | -48.9% | +30.7% |
| 3 y3 years | +13.2% | +54.4% | +55.8% |
| 5 y5 years | -102.1% | +54.4% | +55.8% |
OCX Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +52.7% | -48.9% | +62.0% | -10.0% | +59.2% |
| 5 y | 5-year | -14.4% | +52.7% | -48.9% | +62.0% | -10.0% | +59.2% |
| alltime | all time | -3111.7% | +52.7% | -3121.7% | +62.0% | <-9999.0% | +59.2% |
OncoCyte Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$5.64 M(-8.6%) | -$20.35 M(+10.0%) |
| Jun 2024 | - | -$6.17 M(+60.1%) | -$18.50 M(-3.5%) |
| Mar 2024 | - | -$3.85 M(-17.8%) | -$19.16 M(-18.8%) |
| Dec 2023 | -$23.61 M(-52.7%) | -$4.69 M(+23.8%) | -$23.61 M(-19.6%) |
| Sep 2023 | - | -$3.79 M(-44.6%) | -$29.37 M(-22.4%) |
| Jun 2023 | - | -$6.83 M(-17.7%) | -$37.84 M(-12.8%) |
| Mar 2023 | - | -$8.30 M(-20.6%) | -$43.37 M(-13.1%) |
| Dec 2022 | -$49.91 M(+30.7%) | -$10.45 M(-14.7%) | -$49.91 M(+6.4%) |
| Sep 2022 | - | -$12.26 M(-0.9%) | -$46.92 M(+1.9%) |
| Jun 2022 | - | -$12.37 M(-16.7%) | -$46.05 M(+8.7%) |
| Mar 2022 | - | -$14.84 M(+98.7%) | -$42.35 M(+10.9%) |
| Dec 2021 | -$38.19 M(+40.4%) | -$7.47 M(-34.4%) | -$38.19 M(+3.1%) |
| Sep 2021 | - | -$11.38 M(+31.3%) | -$37.03 M(+15.1%) |
| Jun 2021 | - | -$8.67 M(-18.8%) | -$32.19 M(+3.9%) |
| Mar 2021 | - | -$10.68 M(+69.2%) | -$30.97 M(+13.8%) |
| Dec 2020 | -$27.21 M(+31.9%) | -$6.31 M(-3.4%) | -$27.21 M(+0.4%) |
| Sep 2020 | - | -$6.53 M(-12.4%) | -$27.10 M(+6.6%) |
| Jun 2020 | - | -$7.45 M(+7.8%) | -$25.42 M(+22.1%) |
| Mar 2020 | - | -$6.91 M(+11.4%) | -$20.82 M(+0.9%) |
| Dec 2019 | -$20.63 M | -$6.21 M(+27.9%) | -$20.63 M(+22.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | -$4.85 M(+70.2%) | -$16.88 M(+16.2%) |
| Jun 2019 | - | -$2.85 M(-57.6%) | -$14.52 M(-7.2%) |
| Mar 2019 | - | -$6.72 M(+173.8%) | -$15.65 M(+34.0%) |
| Dec 2018 | -$11.68 M(-13.3%) | -$2.46 M(-1.4%) | -$11.68 M(-7.1%) |
| Sep 2018 | - | -$2.49 M(-37.3%) | -$12.57 M(-7.4%) |
| Jun 2018 | - | -$3.97 M(+44.1%) | -$13.58 M(+5.1%) |
| Mar 2018 | - | -$2.76 M(-17.7%) | -$12.93 M(-4.1%) |
| Dec 2017 | -$13.48 M(+76.7%) | -$3.35 M(-4.3%) | -$13.48 M(+5.9%) |
| Sep 2017 | - | -$3.50 M(+5.4%) | -$12.73 M(+23.9%) |
| Jun 2017 | - | -$3.32 M(+0.4%) | -$10.27 M(+17.3%) |
| Mar 2017 | - | -$3.31 M(+27.1%) | -$8.75 M(+14.7%) |
| Dec 2016 | -$7.63 M(+61.3%) | -$2.60 M(+149.4%) | -$7.63 M(+5.8%) |
| Sep 2016 | - | -$1.04 M(-42.1%) | -$7.21 M(-4.5%) |
| Jun 2016 | - | -$1.80 M(-17.4%) | -$7.55 M(+12.1%) |
| Mar 2016 | - | -$2.18 M(-0.1%) | -$6.74 M(+42.4%) |
| Dec 2015 | -$4.73 M(+303.2%) | -$2.18 M(+57.6%) | -$4.73 M(+85.8%) |
| Sep 2015 | - | -$1.39 M(+40.9%) | -$2.54 M(+119.6%) |
| Jun 2015 | - | -$984.00 K(+462.3%) | -$1.16 M(+562.3%) |
| Mar 2015 | - | -$175.00 K | -$175.00 K |
| Dec 2014 | -$1.17 M(+59.6%) | - | - |
| Dec 2013 | -$735.00 K | - | - |
FAQ
- What is OncoCyte annual free cash flow?
- What is the all time high annual FCF for OncoCyte?
- What is OncoCyte annual FCF year-on-year change?
- What is OncoCyte quarterly free cash flow?
- What is the all time high quarterly FCF for OncoCyte?
- What is OncoCyte quarterly FCF year-on-year change?
- What is OncoCyte TTM free cash flow?
- What is the all time high TTM FCF for OncoCyte?
- What is OncoCyte TTM FCF year-on-year change?
What is OncoCyte annual free cash flow?
The current annual FCF of OCX is -$23.61 M
What is the all time high annual FCF for OncoCyte?
OncoCyte all-time high annual free cash flow is -$735.00 K
What is OncoCyte annual FCF year-on-year change?
Over the past year, OCX annual free cash flow has changed by +$26.30 M (+52.70%)
What is OncoCyte quarterly free cash flow?
The current quarterly FCF of OCX is -$5.64 M
What is the all time high quarterly FCF for OncoCyte?
OncoCyte all-time high quarterly free cash flow is -$175.00 K
What is OncoCyte quarterly FCF year-on-year change?
Over the past year, OCX quarterly free cash flow has changed by -$1.85 M (-48.92%)
What is OncoCyte TTM free cash flow?
The current TTM FCF of OCX is -$20.35 M
What is the all time high TTM FCF for OncoCyte?
OncoCyte all-time high TTM free cash flow is -$175.00 K
What is OncoCyte TTM FCF year-on-year change?
Over the past year, OCX TTM free cash flow has changed by +$9.02 M (+30.71%)